CD58 and diffuse large B-cell lymphoma: Natural killer (NK) cells display the CD2 receptor and are activated by the CD58 ligand, so mutations or deletions in CD58 (21% of all DLBCL and in ABC 68% of the time) cause loss of this extracellular ligand and subsequent failure of NK-mediated cytolysis (Miao et al., 2019).